Million Microbiomes
from Humans project (MMHP)
Vision and Mission
An increasing number of studies has highlighted the important role of the microbiome in human health and disease. However, information on the composition of the microbiome in different parts of the body across countries, ages, sexes, and in relation to human health and disease is still limited. More importantly, though thousands of peer-reviewed papers have been published, very few open access databases are available.
With the featured MGI DNBSEQ™ sequencing technology, the MMHP aims to sequence and analyze one million microbiome samples in the coming 3-5 years, focusing on feces and saliva (other body sites for which large number of samples can be obtained will be accepted), and make the first comprehensive map of the human microbiome publicly available.
With the featured MGI DNBSEQ™ sequencing technology, the MMHP aims to sequence and analyze one million microbiome samples in the coming 3-5 years, focusing on feces and saliva (other body sites for which large number of samples can be obtained will be accepted), and make the first comprehensive map of the human microbiome publicly available.
| Download the Flyer |
Memberships
Chairpersons
- Lars EngstrandDirector of Center for Translational Microbiome Research at Karolina Institute, Sweden
- Stanislav Dusko EhrlichDirector of MetaGenopolis at INRA, France
- Guang NingDirector of Shanghai national Clinical Research Center for Metabolic Diseases, China
- Junhua LiPrincipal Scientist at BGI Research, China
Coordinators
MMHP in 3 numbers
- > 130 000 Samples
- 21 Institutes
- +10 Nations participating in the cohort study
DNBSEQ™ Technology
The project benefit the efficiency and the precision of MGI's technology.
MGI has developed its sequencing proprietary technologies DNBSEQ ™. This patented technology uses rolling circle amplification and patterned array technology to deliver more accurate sequencing data with decreased duplicates and free of index hopping, error accumulation and amplification bias of PCR technology.
MGI has developed its sequencing proprietary technologies DNBSEQ ™. This patented technology uses rolling circle amplification and patterned array technology to deliver more accurate sequencing data with decreased duplicates and free of index hopping, error accumulation and amplification bias of PCR technology.
Interested to join the MMHP? Please, fill the form, our team will contact you
By pressing the send button you agree with the privicy policy of MGI
All photo and video materials belong to their owners and are used for demonstration purposes only. Please do not use them in commercial projects.